AA-115

CAS No. 1818393-16-6

AA-115( AA115 | APG 115 )

Catalog No. M12798 CAS No. 1818393-16-6

AA-115 (APG 115) is a potent and orally active MDM2 inhibitor with Ki <1 nM, potently inhibits SJSA-1 cell growth with IC50 of 60 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 339 In Stock
5MG 560 In Stock
10MG 799 In Stock
25MG 1197 In Stock
50MG 1611 In Stock
100MG 2187 In Stock
500MG 4392 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AA-115
  • Note
    Research use only, not for human use.
  • Brief Description
    AA-115 (APG 115) is a potent and orally active MDM2 inhibitor with Ki <1 nM, potently inhibits SJSA-1 cell growth with IC50 of 60 nM.
  • Description
    AA-115 (APG 115) is a potent and orally active MDM2 inhibitor with Ki <1 nM, potently inhibits SJSA-1 cell growth with IC50 of 60 nM; exhibits IC50 values of 38, 18, and 104 nM in the RS4;11 acute leukemia, LNCaP prostate cancer, and HCT116 colon cancer cell lines, respectively; effectively inhibits tumor growth and causes no or minimal weight loss.
  • In Vitro
    Cell Proliferation Assay Cell Line:AGS and MKN45 cells Concentration:0.0001 μM, 0.001 μM, 0.01 μM, 0.1 μM, 1 μM, 10 μM, 100 μMIncubation Time:72 hours Result:Inhibited cell proliferation in a concentration-dependent manner.RT-PCRCell Line:AGS and MKN45 cells Concentration:0.02 μM, 0.2 μM Incubation Time:48 hours Result:Elevated MDM2, p21, PUMA and BAX mRNA expression.Cell Cycle Analysis Cell Line:AGS and MKN45 cells Concentration:0.02 μM, 0.2 μM Incubation Time:48 hoursResult:Arrested cells at G0/G1 phase.Apoptosis Analysis Cell Line:DePTC p53 wide-type cell line: TPC-1 cells, KTC-1 cells .Concentration:0.3μM, 1μM, 3μM, 10 μM Incubation Time:24 hours Result:Reduced cell population in S-phase, whereas accumulation of cells at G2/M phases.Western Blot Analysis Cell Line:AGS and MKN45 cells Concentration:0.2 μM Incubation Time:72 hours Result:Enhanced expressions of MDM2 and p53, stable knockout of p53 abrogated them.
  • In Vivo
    Animal Model:Four-week-old male BALB/c athymic nude mice with MKN45 cells Dosage:100 mg/kg Administration:Deliverer orally; once daily; 10 days.Result:Decreased xenograft tumor growth.
  • Synonyms
    AA115 | APG 115
  • Pathway
    Apoptosis
  • Target
    MDM2-p53
  • Recptor
    MDM2-p53
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1818393-16-6
  • Formula Weight
    642.593
  • Molecular Formula
    C34H38Cl2FN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (155.62 mM)
  • SMILES
    O=C1NC2=CC(Cl)=CC=C2[C@]13C4(CCCCC4)N(CC)[C@@H](C(NC5(CC6)CCC6(C(O)=O)CC5)=O)[C@@H]3C7=C(F)C(Cl)=CC=C7
  • Chemical Name
    4-((3'R,4'S,5'R)-6''-chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2''-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indoline]-5'-carboxamido)bicyclo[2.2.2]octane-1-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Aguilar A, et al. J Med Chem. 2017 Apr 13;60(7):2819-2839.
molnova catalog
related products
  • p53-MDM2-IN-1

    p53-MDM2-IN-1 (Example 30), an inhibitor of the p53-MDM2/X protein interaction, exhibits a K i value of 23.35 μM and holds potential for applications in anti-tumor research.

  • MI 219

    MI 219 is a potent, specific MDM2-p53 inhibitor with Ki of 5 nM, >10,000-fold selective for MDM2 over MDMX.

  • p53 17-26

    This peptide is amino acids 17 to 26 fragment of p53, the Mdm-2 binding domain of p53 known also as p53N. This sequence contains all of the residues that contact the binding domain of Mdm-2.